Log in to save to my catalogue

Outcomes of Direct Oral Anticoagulants Co-Prescribed with Common Interacting Medications

Outcomes of Direct Oral Anticoagulants Co-Prescribed with Common Interacting Medications

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8678337

Outcomes of Direct Oral Anticoagulants Co-Prescribed with Common Interacting Medications

About this item

Full title

Outcomes of Direct Oral Anticoagulants Co-Prescribed with Common Interacting Medications

Publisher

United States: Elsevier Inc

Journal title

The American journal of cardiology, 2022-01, Vol.162, p.80-85

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Direct oral anticoagulants (DOACs) can potentially interact with multiple prescription medications. We examined the prevalence of co-prescription of DOACs with interacting medications and its impact on outcomes in patients with atrial fibrillation (AF). Patients with AF treated with a DOAC from 2010 to 2017 at the Mayo Clinic and co-prescribed medi...

Alternative Titles

Full title

Outcomes of Direct Oral Anticoagulants Co-Prescribed with Common Interacting Medications

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8678337

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8678337

Other Identifiers

ISSN

0002-9149

E-ISSN

1879-1913

DOI

10.1016/j.amjcard.2021.09.025

How to access this item